Stay updated on AK104 with Chemotherapy in First-line ESCC Clinical Trial
Sign up to get notified when there's something new on the AK104 with Chemotherapy in First-line ESCC Clinical Trial page.

Latest updates to the AK104 with Chemotherapy in First-line ESCC Clinical Trial page
- Check2 days agoChange DetectedThe revision label on the study record history page was updated from v3.6.3 to v3.6.4, reflecting a software update to the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe study history now includes a new revision entry v3.6.3, representing the latest update to the record. The previous revision v3.6.2 is removed from the history display.SummaryDifference0.1%

- Check30 days agoChange DetectedThe record history adds a new revision entry (v3.6.2) and removes the older revision (v3.6.0), updating the page's version history. This is an administrative update to the page's metadata rather than substantive changes to the study content.SummaryDifference0.1%

- Check45 days agoChange DetectedThe record history metadata was updated to separate verifier attribution from the institution, adding 'Jing Huang,' and the labels 'Last verified' and 'Last known status was,' with the revision version updated to v3.6.0. This change clarifies who validated the data and updates the revision tracking within the study history.SummaryDifference3%

- Check52 days agoChange DetectedRecord history now shows Revision: v3.5.5 replacing Revision: v3.5.4, indicating a minor update to the page’s revision history.SummaryDifference0.1%

- Check73 days agoChange DetectedNew revision entry v3.5.4 has been added to the study's record history, and the previous revision v3.5.3 has been removed, updating the audit trail to reflect the latest changes.SummaryDifference0.1%

Stay in the know with updates to AK104 with Chemotherapy in First-line ESCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 with Chemotherapy in First-line ESCC Clinical Trial page.